Financials
- Market Capitalization 1.74 B
- Employee 415
- Founded 2014
- CEO N/A
- Website www.maravai.com
- Headquarter Delaware, United States
- FIGI BBG00Y1DFV91
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.61
売上高対価格比率
2.53
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2019 | TRVI Trevi Therapeutics, Inc. - Common Stock | 12.50 USD | -3.33% | -5.37% | -21.88% | +30.89% | 1.78 B USD | ||
| 2020 | ZYME Zymeworks Inc. - Common Stock | 25.13 USD | -0.79% | -2.75% | -6.23% | +41.66% | 1.78 B USD | ||
| 2032 | SEPN Septerna, Inc. - Common Stock | 37.88 USD | +0.85% | +5.08% | -2.02% | +72.10% | 1.77 B USD | ||
| 2036 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 16.70 USD | -4.24% | -3.19% | -18.73% | -22.61% | 1.76 B USD |